Correction: Olaparib-mediated enhancement of 5-fluorouracil cytotoxicity in mismatch repair deficient colorectal cancer cells - Summary - MDSpire

Correction: Olaparib-mediated enhancement of 5-fluorouracil cytotoxicity in mismatch repair deficient colorectal cancer cells

  • By

  • Helena de Castro e Gloria

  • Laura Jesuíno Nogueira

  • Patrícia Bencke Grudzinski

  • Paola Victória da Costa Ghignatti

  • Temenouga Nikolova Guecheva

  • Natalia Motta Leguisamo

  • Jenifer Saffi

  • July 1, 2026

  • 0 min

Share

Objective:

To correct an image duplication error in a previously published article.

Approach:
  • Correction Details: An image duplication was identified in Fig. 7C, where the image for the HCT116 5-FU 5 µM + Olaparib 5 µM condition was incorrectly used for the HCT116 5-FU 5 µM condition.
Key Findings:
  • The quantitative analysis was performed on original sample slides, independent of the representative images.
  • The replacement of the image does not affect the reported results and conclusions.
Interpretation:

The correction clarifies the integrity of the data presented in the original study.

Conclusion:

The original article has been updated to reflect the correct image.

Sources:

Original Source(s)

Correction: Olaparib-mediated enhancement of 5-fluorouracil cytotoxicity in mismatch repair deficient colorectal cancer cells

  • by Helena de Castro e Gloria, Laura Jesuíno Nogueira, Patrícia Bencke Grudzinski, Paola Victória da Costa Ghignatti, Temenouga Nikolova Guecheva, Natalia Motta Leguisamo, Jenifer Saffi

  • July 1, 2026

Related Content

Alectinib combined with 5-aminolevulinic acid-based photodynamic therapy promotes apoptosis in endometrial cancer cells by targeting ferrochelatase

Breast Cancer Incidence in Asian American, Native Hawaiian, and Pacific Islander Populations

Case Report: Trazodone as a possible treatment for psychiatric adverse events related to ALK inhibitors